tradingkey.logo

tradingkey.logo
怜玢


Werewolf Therapeutics Inc

HOWL
りォッチリストに远加
0.980USD
0.0000.00%
終倀 11-13 16:00ET
47.63M時䟡総額
損倱額盎近12ヶ月PER
時間倖取匕 16:09 (ET)0.950USD-0.030-3.06%

Werewolf Therapeutics Incに぀いお 䌁業名

Werewolf Therapeutics, Inc. is a biopharmaceutical company engaged in the development of therapeutics engineered to stimulate the body’s immune system for the treatment of cancer and other immune-mediated conditions. It is leveraging its PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. Its INDUKINE molecules are intended to remain inactive in peripheral tissue yet activate selectively in the tumor microenvironment. The Company’s advanced clinical-stage product candidates, WTX-124 and WTX-330, are systemically delivered, conditionally activated Interleukin-2 (IL-2) and IL-12 INDUKINE molecules for the treatment of solid tumors. It is advancing WTX-124 in multiple tumor types as a single agent and in combination with an immune checkpoint inhibitor. It is advancing WTX-712, WTX-518, and WTX-921 through preclinical development.

Werewolf Therapeutics Inc プロフィヌル


䌁業コヌドHOWL
䌚瀟名Werewolf Therapeutics Inc
䞊堎日Apr 30, 2021
最高経営責任者「CEO」Hicklin (Daniel J)
埓業員数46
蚌刞皮類Ordinary Share
決算期末Apr 30
本瀟所圚地200 Talcott Avenue
郜垂WATERTOWN
蚌刞取匕所NASDAQ OMX - NASDAQ BASIC
囜United States of America
郵䟿番号02472
電話番号16179520555
りェブサむトhttps://werewolftx.com/
䌁業コヌドHOWL
䞊堎日Apr 30, 2021
最高経営責任者「CEO」Hicklin (Daniel J)

Werewolf Therapeutics Incの経営陣


䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Dr. Luke Evnin, Ph.D.
Dr. Luke Evnin, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Dr. Chulani Karunatilake, Ph.D.
Dr. Chulani Karunatilake, Ph.D.
Chief Technology Officer
Chief Technology Officer
--
--
Dr. Meeta Chatterjee, Ph.D.
Dr. Meeta Chatterjee, Ph.D.
Independent Director
Independent Director
--
--
Dr. Michael B. Atkins, M.D.
Dr. Michael B. Atkins, M.D.
Independent Director
Independent Director
--
--
Dr. Anil Singhal, Ph.D.
Dr. Anil Singhal, Ph.D.
Independent Director
Independent Director
--
--
Mr. Steven Bloom
Mr. Steven Bloom
Chief Business Officer
Chief Business Officer
--
--
Mr. Michael Urban
Mr. Michael Urban
Principal Financial Officer, Principal Accounting Officer
Principal Financial Officer, Principal Accounting Officer
--
--
Dr. Daniel J. (Dan) Hicklin, Ph.D.
Dr. Daniel J. (Dan) Hicklin, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Michael A. (Mike) Sherman
Mr. Michael A. (Mike) Sherman
Independent Director
Independent Director
--
--
Mr. Steven Bloom
Mr. Steven Bloom
Chief Business Officer
Chief Business Officer
--
--
詳现を芋る
䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Dr. Luke Evnin, Ph.D.
Dr. Luke Evnin, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Dr. Chulani Karunatilake, Ph.D.
Dr. Chulani Karunatilake, Ph.D.
Chief Technology Officer
Chief Technology Officer
--
--
Dr. Meeta Chatterjee, Ph.D.
Dr. Meeta Chatterjee, Ph.D.
Independent Director
Independent Director
--
--
Dr. Michael B. Atkins, M.D.
Dr. Michael B. Atkins, M.D.
Independent Director
Independent Director
--
--
Dr. Anil Singhal, Ph.D.
Dr. Anil Singhal, Ph.D.
Independent Director
Independent Director
--
--
Mr. Steven Bloom
Mr. Steven Bloom
Chief Business Officer
Chief Business Officer
--
--

よくある質問

Werewolf Therapeutics Incの䞊䜍5名の株䞻は誰ですか


Werewolf Therapeutics Incの䞊䜍5名の株䞻は以䞋のずおりです。Dr. Daniel J. (Dan) Hicklin, Ph.D.

Werewolf Therapeutics IncHOWLの株匏を保有しおいる機関の数はいく぀ですか


2026Q1時点で、Werewolf Therapeutics Incの株匏を保有しおいる機関は166瀟あり、保有株匏の総垂堎䟡倀は玄21.18Mで、党䜓の43.59%を占めおいたす。2025Q4ず比范しお、機関の持ち株は-7759273.00増加しおいたす。
tradingkey.logo
リスク告知圓瀟りェブサむト及びモバむルアプリは特定の投資商品に関する䞀般的な情報のみを提䟛しおおり、Finsightsは金融アドバむスや投資商品の掚奚を行うものではありたせん。本情報の提䟛をもっおFinsightsが投資助蚀を行っおいるず解釈されるこずはありたせん。
投資商品には元本割れを含む重倧なリスクが䌎い、党おの投資家に適するものではありたせん。なお、過去の運甚実瞟は将来の成果を保蚌するものではありたせん。
Finsightsは、第䞉者広告䞻たたは提携先が圓瀟りェブサむト・モバむルアプリ䞊に広告を掲茉するこずを蚱可する堎合があり、これら広告䞻から広告ぞの反応に基づく報酬を受けるこずがありたす。
© 著䜜暩: FINSIGHTS MEDIA PTE. LTD. 無断耇写・転茉を犁じたす。